Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™

Jagdishbhai L Italia, Andrew Sharp, Katharine C Carter, Peter Warn, M N V Ravi Kumar

Research output: Contribution to journalArticlepeer-review

49 Citations (Scopus)
57 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science